The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
Earmarks are back, and one state’s health care industry is cashing in
